| Literature DB >> 24900463 |
Roberto Pellicciari1, Antimo Gioiello1, Paola Sabbatini1, Francesco Venturoni1, Roberto Nuti1, Carolina Colliva2, Giovanni Rizzo3, Luciano Adorini3, Mark Pruzanski3, Aldo Roda2, Antonio Macchiarulo1.
Abstract
Grounding on our former 3D QSAR studies, a knowledge-based screen of natural bile acids from diverse animal species has led to the identification of avicholic acid as a selective but weak TGR5 agonist. Chemical modifications of this compound resulted in the disclosure of 6α-ethyl-16-epi-avicholic acid that shows enhanced potency at TGR5 and FXR receptors. The synthesis, biological appraisals, and structure-activity relationships of this series of compounds are herein described. Moreover, a thorough physicochemical characterization of 6α-ethyl-16-epi-avicholic acid as compared to naturally occurring bile acids is reported and discussed.Entities:
Keywords: 16-epi-avicholic acid; CMC; FXR; TGR5; avicholic acid; bile acid; structure−activity relationship
Year: 2012 PMID: 24900463 PMCID: PMC4025660 DOI: 10.1021/ml200256d
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345